Cargando…

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs

Detalles Bibliográficos
Autor principal:	Kim, Sang-Heon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840867/ https://www.ncbi.nlm.nih.gov/pubmed/33474854 http://dx.doi.org/10.4168/aair.2021.13.2.173

Ejemplares similares

Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs
por: Lee, Suh-Young, et al.
Publicado: (2018)

Spectrum of Cutaneous Adverse Drug Reactions to Anti-tubercular Drugs and Safe Therapy after Re-challenge - A Retrospective Study
por: Sharma, Reena K., et al.
Publicado: (2020)

Sutton's law and severe cutaneous adverse drug reactions: Is the money in the blister?
por: Chow, Timothy G., et al.
Publicado: (2021)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs
por: Imam, Faisal, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients
por: Jin, Hyun Jung, et al.
Publicado: (2020)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint
por: Shafiq, Nusrat, et al.
Publicado: (2022)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs
por: Park, Heung-Woo, et al.
Publicado: (2018)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Severe Adverse Drug Reactions in Korean Elderly Patients
por: Lee, Jungun
Publicado: (2022)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
por: Yang, Min-Suk, et al.
Publicado: (2019)

Are the Present Doses of Anti Tubercular Drugs Adequate for Severe Disease?
por: Marais, Suzaan, et al.
Publicado: (2015)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea
por: Park, Chan Sun, et al.
Publicado: (2019)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

A Pilot Trial of Jawarish Amla as Adjuvant to Anti-Tubercular Treatment Drugs for Control of Adverse Reactions in DOTS Regime in Pulmonary TB
por: Sherwani, Arish Mohammad Khan, et al.
Publicado: (2013)

Evaluation of medical adherence, adverse drug reactions, and quality of life in post tubercular obstructive airway disease
por: Awasthi, Vinita, et al.
Publicado: (2023)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

The Role of Frozen Section in the Rapid Diagnosis of Severe Cutaneous Adverse Drug Reactions
por: Nicholas, Rajam, et al.
Publicado: (2021)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Severe cutaneous adverse drug reactions of Chinese inpatients: a meta-analysis
por: Qiancheng, Deng, et al.
Publicado: (2017)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana
por: Amalba, Anthony, et al.
Publicado: (2021)

A Severe Case of Cutaneous Adverse Drug Reaction Secondary to a Novice Drug: Idelalisib
por: Gabriel, Joseph Gabriel, et al.
Publicado: (2017)

The Tubercular Origin of Joint Diseases
Publicado: (1884)

Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs
por: Zhang, Jingang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j7qniujhsi1j6p3q5b4878drbu